PDF《References (1996)》

Blumenfeld I;

Blumenfeld Z [Therapeutic potential of ozoneCpossible side-effects] Harefuah 130: 327-30 (1996) Ayyavoo V;

Ugen KE;

Fernandes LS;

Goedert JJ;

Rubinstein A;

Williams WV;

Weiner DB Analysis of genetic heterogeneity, antigenicity, and biolog- ical characteristics of HIV-1 in a maternal transmitter and nontransmitter patient pair. DNA Cell Biol 15: 571-80 (1996) Back NK;

Nijhuis M;

Keulen W;

Boucher CA;

Oude Essink BO;

van Kuilenburg AB;

van Gennip AH;

Berkhout B Reduced replication of 3TC-resistant HIV-1 variants in pri- mary cells due to a processivity defect of the reverse tran- scriptase enzyme. EMBO J 15: 4040-9 (1996) Back NK;

Nijhuis M;

Keulen W;

Boucher CA;

Oude Essink BO;

van Kuilenburg AB;

van Gennip AH;

Berkhout B Reduced replication of 3TC-resistant HIV-1 variants in pri- mary cells due to a processivity defect of the reverse tran- scriptase enzyme. EMBO J 15: 4040-9 (1996) References (1996) V-17 DEC

96 Badley AD;

McElhinny JA;

Leibson PJ;

Lynch DH;

Alderson MR;

Paya CV Upregulation of Fas ligand expression by human immuno- de?ciency virus in human macrophages mediates apoptosis of uninfected T lymphocytes. J Virol 70: 199-206 (1996) Bagetta G;

Corasaniti MT;

Aloe L;

Berliocchi L;

Costa N;

Finazzi- Agro A;

Nistico G Intracerebral injection of human immunode?ciency virus type

1 coat protein gp120 differentially affects the expres- sion of nerve growth factor and nitric oxide synthase in the hippocampus of rat. Proc Natl Acad Sci U S A 93: 928-33 (1996) Bahner I;

Kearns K;

Hao QL;

Smogorzewska EM;

Kohn DB Transduction of human CD34+ hematopoietic progenitor cells by a retroviral vector expressing an RRE decoy in- hibits human immunode?ciency virus type

1 replication in myelomonocytic cells produced in long-term culture. J Virol 70: 4352-60 (1996) Bailly C;

Colson P;

Houssier C;

Hamy F The binding mode of drugs to the TAR RNA of HIV-1 studied by electric linear dichroism. Nucleic Acids Res 24: 1460-4 (1996) Bakhanashvili M;

Avidan O;

Hizi A Mutational studies of human immunode?ciency virus type

1 reverse transcriptase: the involvement of residues

183 and

184 in the ?delity of DNA synthesis. FEBS Lett 391: 257-62 (1996) Balachandran R;

Singh MK;

Gupta P An additional mechanism of growth restriction in T cell line H9 of human immunode?ciency virus type

1 isolates from asymptomatic homosexual men. J Gen Virol

77 ( Pt 5): 1083-8 (1996) Balakrishnan M;

Zastrow D;

Jonsson CB Catalytic activities of the human T-cell leukemia virus type II integrase. Virology 219: 77-86 (1996) Balzarini J;

Aquaro S;

Perno CF;

Witvrouw M;

Holy A;

De Clercq E Activity of the (R)-enantiomers of 9-(2-phosphonylmethoxypropyl)-adenine and 9-(2-phosphonylmethoxypropyl)-2,6-diaminopurine against human immunode?ciency virus in different human cell sys- tems. Biochem Biophys Res Commun 219: 337-41 (1996) Balzarini J;

Pelemans H;

Aquaro S;

Perno CF;

Witvrouw M;

Schols D;

De Clercq E;

Karlsson A Highlyfavorableantiviralactivityandresistancepro?leofthe novel thiocarboxanilide pentenyloxy ether derivatives UC-

781 and UC-82 as inhibitors of human immunode?ciency virus type

1 replication. Mol Pharmacol 50: 394-401 (1996) Balzarini J;

Pelemans H;

........